UniProt ID | TRI56_HUMAN | |
---|---|---|
UniProt AC | Q9BRZ2 | |
Protein Name | E3 ubiquitin-protein ligase TRIM56 | |
Gene Name | TRIM56 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 755 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | E3 ubiquitin-protein ligase that plays a key role in innate antiviral immunity. [PubMed: 21289118 In response to pathogen- and host-derived double-stranded DNA (dsDNA), targets TMEM173/STING to 'Lys-63'-linked ubiquitination, thereby promoting its homodimerization, a step required for the production of type I interferon IFN-beta (By similarity Independently of its E3 ubiquitin ligase activity, positive regulator of TLR3 signaling. Potentiates extracellular double stranded RNA (dsRNA)-induced expression of IFNB1 and interferon-stimulated genes ISG15, IFIT1/ISG56, CXCL10, OASL and CCL5/RANTES. Promotes establishment of an antiviral state by TLR3 ligand and TLR3-mediated chemokine induction following infection by hepatitis C virus] | |
Protein Sequence | MVSHGSSPSLLEALSSDFLACKICLEQLRAPKTLPCLHTYCQDCLAQLADGGRVRCPECRETVPVPPEGVASFKTNFFVNGLLDLVKARACGDLRAGKPACALCPLVGGTSTGGPATARCLDCADDLCQACADGHRCTRQTHTHRVVDLVGYRAGWYDEEARERQAAQCPQHPGEALRFLCQPCSQLLCRECRLDPHLDHPCLPLAEAVRARRPGLEGLLAGVDNNLVELEAARRVEKEALARLREQAARVGTQVEEAAEGVLRALLAQKQEVLGQLRAHVEAAEEAARERLAELEGREQVARAAAAFARRVLSLGREAEILSLEGAIAQRLRQLQGCPWAPGPAPCLLPQLELHPGLLDKNCHLLRLSFEEQQPQKDGGKDGAGTQGGEESQSRREDEPKTERQGGVQPQAGDGAQTPKEEKAQTTREEGAQTLEEDRAQTPHEDGGPQPHRGGRPNKKKKFKGRLKSISREPSPALGPNLDGSGLLPRPIFYCSFPTRMPGDKRSPRITGLCPFGPREILVADEQNRALKRFSLNGDYKGTVPVPEGCSPCSVAALQSAVAFSASARLYLINPNGEVQWRRALSLSQASHAVAALPSGDRVAVSVAGHVEVYNMEGSLATRFIPGGKASRGLRALVFLTTSPQGHFVGSDWQQNSVVICDGLGQVVGEYKGPGLHGCQPGSVSVDKKGYIFLTLREVNKVVILDPKGSLLGDFLTAYHGLEKPRVTTMVDGRYLVVSLSNGTIHIFRVRSPDS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MVSHGSSPSL -----CCCCCCCHHH | 22.34 | 28464451 | |
6 | Phosphorylation | --MVSHGSSPSLLEA --CCCCCCCHHHHHH | 33.38 | 25159151 | |
7 | Phosphorylation | -MVSHGSSPSLLEAL -CCCCCCCHHHHHHH | 24.09 | 28464451 | |
9 | Phosphorylation | VSHGSSPSLLEALSS CCCCCCHHHHHHHCC | 47.75 | 28464451 | |
15 | Phosphorylation | PSLLEALSSDFLACK HHHHHHHCCCHHHHH | 34.60 | 26552605 | |
16 | Phosphorylation | SLLEALSSDFLACKI HHHHHHCCCHHHHHH | 32.98 | 26074081 | |
62 | Phosphorylation | RCPECRETVPVPPEG ECCCCCCCCCCCCCC | 15.68 | - | |
72 | Phosphorylation | VPPEGVASFKTNFFV CCCCCCCCCCCCCCH | 25.52 | 24719451 | |
87 | Ubiquitination | NGLLDLVKARACGDL HCHHHHHHHHHCCCC | 39.18 | 23000965 | |
98 | Ubiquitination | CGDLRAGKPACALCP CCCCCCCCCEEEECC | 28.58 | - | |
117 | Phosphorylation | TSTGGPATARCLDCA CCCCCHHHHHHHHCH | 20.12 | 25137130 | |
157 | Phosphorylation | VGYRAGWYDEEARER HHHCCCCCCHHHHHH | 16.74 | 27642862 | |
253 | Phosphorylation | EQAARVGTQVEEAAE HHHHHHCCHHHHHHH | 26.95 | 21406692 | |
270 | Ubiquitination | LRALLAQKQEVLGQL HHHHHHHHHHHHHHH | 42.70 | 23000965 | |
369 | Phosphorylation | NCHLLRLSFEEQQPQ CCEEEEEECCCCCCC | 24.95 | 20873877 | |
377 | Ubiquitination | FEEQQPQKDGGKDGA CCCCCCCCCCCCCCC | 66.09 | 24816145 | |
381 | Ubiquitination | QPQKDGGKDGAGTQG CCCCCCCCCCCCCCC | 59.52 | 33845483 | |
392 | Phosphorylation | GTQGGEESQSRREDE CCCCCCHHHCCCCCC | 29.20 | 24275569 | |
418 | Phosphorylation | QAGDGAQTPKEEKAQ CCCCCCCCCHHHHCH | 35.48 | 29255136 | |
426 | Phosphorylation | PKEEKAQTTREEGAQ CHHHHCHHCHHHHCH | 32.45 | 23186163 | |
427 | Phosphorylation | KEEKAQTTREEGAQT HHHHCHHCHHHHCHH | 24.81 | 24505115 | |
434 | Phosphorylation | TREEGAQTLEEDRAQ CHHHHCHHHHHHHCC | 35.29 | 22167270 | |
442 | Phosphorylation | LEEDRAQTPHEDGGP HHHHHCCCCCCCCCC | 26.15 | 30266825 | |
469 | Phosphorylation | KFKGRLKSISREPSP HHCCHHHHCCCCCCC | 30.32 | 29255136 | |
471 | Phosphorylation | KGRLKSISREPSPAL CCHHHHCCCCCCCCC | 37.37 | 29255136 | |
475 | Phosphorylation | KSISREPSPALGPNL HHCCCCCCCCCCCCC | 20.32 | 29255136 | |
485 | Phosphorylation | LGPNLDGSGLLPRPI CCCCCCCCCCCCCCE | 26.40 | 30266825 | |
494 | Phosphorylation | LLPRPIFYCSFPTRM CCCCCEEEEECCCCC | 6.47 | 23090842 | |
496 | Phosphorylation | PRPIFYCSFPTRMPG CCCEEEEECCCCCCC | 23.92 | 23090842 | |
499 | Phosphorylation | IFYCSFPTRMPGDKR EEEEECCCCCCCCCC | 37.27 | 22115753 | |
554 | Phosphorylation | PEGCSPCSVAALQSA CCCCCHHHHHHHHHH | 20.41 | 32142685 | |
567 | Phosphorylation | SAVAFSASARLYLIN HHHHHCCCCEEEEEC | 16.84 | 32142685 | |
688 | Ubiquitination | PGSVSVDKKGYIFLT CCCEEECCCCEEEEE | 46.04 | 29967540 | |
710 | Phosphorylation | VILDPKGSLLGDFLT EEECCCCCCHHHHHH | 26.92 | 22817900 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRI56_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRI56_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRI56_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
STING_HUMAN | TMEM173 | physical | 21074459 | |
TCAM1_HUMAN | TICAM1 | physical | 22948160 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-418; THR-442 ANDSER-475, AND MASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-710, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-469; SER-471 ANDSER-475, AND MASS SPECTROMETRY. |